HIV-1 Group O Reverse Transcriptase Mutations for High-Temperature Activity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current reverse transcriptases used in biotechnological applications, such as RT-PCR, face limitations in thermal stability and fidelity at elevated temperatures, particularly above 52 °C, which affects the amplification of RNAs with secondary structures or G:C-rich sequences.
Innovation Solution
Development of reverse transcriptases from HIV-1 group O with specific amino acid modifications, including K358R/A359G/S360A, T69SSG/K358R/A359G/S360A, T355A/Q357M/K358R/A359G/S360A, and E478Q, which exhibit enhanced thermostability and fidelity, allowing for efficient DNA synthesis at temperatures exceeding 75 °C, expressed and purified in bacteria like Escherichia coli.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Temperature
If conventional reverse transcriptases (AMV RT, MLV RT) are used for RNA amplification, then they can perform reverse transcription at moderate temperatures (42-52 °C), but they lose activity and thermal stability at elevated temperatures above 52 °C
Solution Approach 1:
The patent applies parameter changes by modifying the amino acid sequence of the reverse transcriptase enzyme through site-directed mutagenesis. Specific mutations (K358R, A359G, S360A, T69SSG, T355A, Q357M, E478Q) were introduced to alter the enzyme's thermal stability parameters, enabling it to maintain activity at elevated temperatures up to 75-80 °C while preserving its catalytic function
Solution Approach 2:
The patent creates a composite enzyme structure by combining multiple mutations within the reverse transcriptase protein. The synergistic effect of seven different amino acid substitutions produces an enzyme with enhanced thermostability that exceeds the sum of individual mutation effects, achieving superior thermal resistance while maintaining catalytic activity
2Temperature
If HIV-1 group O reverse transcriptase with mutations K358R/A359G/S360A is used, then thermostability and activity at elevated temperatures are improved, but the enzyme structure is modified
Solution Approach 1:
The patent applies local quality by introducing mutations at specific localized positions within the reverse transcriptase protein structure. The seven mutation sites are strategically distributed across different functional domains, with each location carefully selected to enhance thermal stability without disrupting critical catalytic residues or substrate binding regions
Solution Approach 2:
The patent changes physical-chemical parameters of the enzyme by substituting amino acids with different properties. For example, K358R changes a basic residue to another basic residue with different stability properties, while T69SSG inserts additional residues to strengthen local structure, collectively enhancing thermostability while preserving function
3Adaptability or versatility
If reverse transcriptases are used for RNAs with secondary structures or G:C-rich sequences, then amplification of these difficult templates is needed, but conventional enzymes lack sufficient activity at the high temperatures required to melt these structures
Solution Approach 1:
The patent changes the operational temperature parameter of the reverse transcriptase enzyme through structural modifications. The mutated enzyme maintains catalytic activity at temperatures up to 75-80 °C, which is sufficient to melt secondary structures and G:C-rich sequences, enabling amplification of difficult RNA templates that conventional enzymes cannot process
Solution Approach 2:
The patent applies preliminary action by performing reverse transcription at elevated temperatures before PCR amplification. The thermostable reverse transcriptase first synthesizes cDNA from the difficult RNA template at high temperature (75-80 °C), melting secondary structures in advance, and then the resulting cDNA is amplified by conventional PCR, achieving successful amplification of templates that would otherwise be refractory
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These modified reverse transcriptases demonstrate increased activity and maintained fidelity at high temperatures, improving the yield and accuracy of nucleic acid amplification, especially for RNAs with secondary structures, thereby enhancing biotechnological applications like RT-PCR and sequencing.
Implementation Method 1
reverse transcriptases isolated from a human immunodeficiency virus type 1 group O (HIV-1) and modified in one or more positions that have higher thermostability than the original enzyme, maintaining copying fidelity
Implementation Method 2
RT converts the single-stranded RNA genome into double-stranded DNA capable of integration into the genome of the host cell
Data Source
Figure 1A
Figure 1B
Figure 2
AI summary
The present invention falls within the field of biotechnology. More specifically, the invention relates to reverse transcriptases expressed and purified in bacteria and having the amino acid sequence of the reverse transcriptase of a human immunodeficiency virus type 1 (HIV-1) group O, modified at positions 358, 359 and 360; and variants of this enzyme that contain additional changes at positions 355 and 357 or at 478 or position 69 (in this case accompanied by an insertion of two amino acids). These polymerases have greater activity than the non-mutated enzyme at high temperatures (above 60 C). In addition, they retain the capacity for DNA synthesis at temperatures greater than 70 C. Moreover, the copying fidelity of these enzymes is not significantly different from that of the non-mutated reverse transcriptase